Original Research
Published on 27 Jul 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
in Genitourinary Oncology
- 3,061 views
- 3 citations